The Toronto Stock Exchange reports that Cipher Pharmaceuticals Inc. has had a change in its reporting status. Effective at the open on Nov. 13, 2023, the company is exempt from the reporting requirements of Section 501 of the TSX company manual.
© 2024 Canjex Publishing Ltd. All rights reserved.